• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2500242 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2025-10-10 Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG view
JYSB2500240 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2025-10-10 Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG view
JYSB2500243 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2025-10-10 Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG view
JYSB2500241 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2025-10-10 Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG view
CYSB2500262 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2025-10-10 Shanghai Fuhong Ruilin Biotechnology Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2500244 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) Supplementary Application 2025-09-25 SinoCelltech Ltd view
CYSB2500208 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2025-09-13 Innovent Biologics (Suzhou) Co Ltd view
JYSB2500183 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2025-08-15 Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG view
JYSB2500184 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2025-08-15 Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG view
CYSB2500144 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) Supplementary Application 2025-07-01 Mabwell (Shanghai) Bioscience Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd view
CXSS2500061 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) New Drug Application 2025-06-10 Sichuan Luzhou Bubu Biopharmaceutical Co Ltd;Beijing Joinn Biologics Co Ltd view
CYSB2500074 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2025-04-03 Shanghai Fuhong Ruilin Biotechnology Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd view
CXSS2400138 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) New Drug Application 2024-12-14 Zhejiang HUAHAI Biopharmaceuticals Co Ltd view
CYSB2400326 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2024-12-14 Shanghai Junshi Biosciences Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd view
CYSB2400263 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) Supplementary Application 2024-09-28 SinoCelltech Ltd view
JYSZ2400050 阿达木单抗注射液 adalimumab Injection Biological Products License Renew 2024-09-04 Vetter Pharma-Fertigung Gmbh & Co KG;AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG view
CYSB2400155 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2024-06-18 Hisun Biopharmaceutical Co Ltd view
CYSB2400125 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) Supplementary Application 2024-05-22 SinoCelltech Ltd view
JYSZ2400024 阿达木单抗注射液 adalimumab Injection Biological Products License Renew 2024-05-14 Vetter Pharma-Fertigung Gmbh & Co KG;AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG view
JYSZ2400023 阿达木单抗注射液 adalimumab Injection Biological Products License Renew 2024-05-14 Vetter Pharma-Fertigung Gmbh & Co KG;AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG view